CompareSupplements

Hashimoto'svsGraves'

Both are autoimmune thyroid disease, both run in families and both can show TPO antibodies. TSH moves in opposite directions in the two, and one antibody, TRAb, names Graves'.

The short answer

The difference between Hashimoto's and Graves' is direction. Both are autoimmune thyroid diseases, but in Hashimoto's immune cells slowly destroy the gland, so it becomes underactive (a high TSH, the pituitary's "work harder" signal, with a low or normal free T4, the main thyroid hormone) and is treated by replacing the hormone with levothyroxine. In Graves', an antibody switches on the TSH receptor, so the gland overproduces hormone (low TSH, high free T4) and is treated by slowing it with methimazole, radioactive iodine or surgery. The test that tells them apart is the TSH receptor antibody (TRAb), positive in about 98% of people with untreated Graves'. TPO antibodies cannot separate the two, because they show up in both diseases and in about 11% of Americans with no thyroid disease.

Ask AI about this pageChatGPTClaudePerplexity
SupplementHashimoto'sNot one we carry. The comparison below covers it in full.
SupplementGraves'Not one we carry. The comparison below covers it in full.

Side by side

Hashimoto'sGraves'
Thyroid outputFalls slowly, over yearsRises, often over weeks to months
Free T3Low or normalHigh; sometimes rises before free T4 (T3 vs T4)
TPO antibodiesThe main marker, positive in about 90 to 95% 3Also positive, in about 70 to 80% 5
Thyroglobulin antibodiesPositive in a smaller share; useful when TPO is negative 3Sometimes positive; not used for diagnosis
TSH receptor antibody (TRAb)Usually negativePositive in about 98% of untreated cases 2
NeckFirm goiter (enlarged thyroid), or a small shrunken glandSmooth, evenly enlarged goiter
UltrasoundDarker (hypoechoic), uneven texture 3Hypoechoic with very high blood flow on Doppler (a blood-flow ultrasound) 1
Radioactive iodine uptake scan (how much iodine the gland soaks up)Rarely needed; low during a temporary overactive phaseHigh and even across the gland; rarely needed when TRAb is positive 14
Long-term courseMost forms eventually become permanently underactive, often over many years 3About half stay in remission after a full drug course 1
Who gets itWomen far more than men; rises with age; the most common autoimmune disease 3About 3% of women and 0.5% of men over a lifetime 1

The differences that matter

  1. 01
    TPO antibodies say autoimmune; TRAb says Graves'

    A positive TPO antibody test tells you the immune system is reacting to the thyroid. It turns up in most people with Hashimoto's, most people with Graves' and about 1 in 9 Americans with no thyroid disease, so on its own it cannot say which disease is behind it. TSH tells you the direction (high means underactive, low means overactive), and the TSH receptor antibody (TRAb) is the result that names Graves'.

If your report shows a positive thyroid antibody, check two things before anything else: which way your TSH moved, and which antibody came back positive. Hashimoto's and Graves' run in the same families and share early complaints such as tiredness, poor sleep and a changed mood. The lab pattern separates them in most people, and the people who fit neither picture get their own sections below. Any TSH or free T4 outside its range, or a new positive antibody, is one to go through with your clinician; these patterns explain the report, and the diagnosis is theirs to make.

Hashimoto's slows the thyroid down; Graves' speeds it up

Hashimoto's diseaseUnderactive: replace the hormone
Autoimmune (Hashimoto's) thyroiditis
What the immune system doesImmune cells move in and destroy thyroid tissue
TSHHigh (normal in early years)
Free T4Low or normal
Signature antibodyTPO antibodies, in about 90 to 95%
EyesRarely affected
Usual treatmentLevothyroxine once hormone falls
Graves' diseaseOveractive: slow the gland
Autoimmune hyperthyroidism
What the immune system doesAn antibody switches the TSH receptor on
TSHLow, often undetectable
Free T4High (free T3 often higher still)
Signature antibodyTRAb, in about 98% of untreated cases
EyesEye disease in about 1 in 4
Usual treatmentMethimazole, radioactive iodine or surgery
Antibody rates: TPO antibodies in Hashimoto's from Caturegli and colleagues 3; TRAb sensitivity from a 21-study meta-analysis 2; eye disease from the 2021 EUGOGO guideline 12; treatment options from the 2018 European Thyroid Association guideline 1.

Hashimoto's vs Graves' side by side

Same root, opposite direction: what the antibodies do

Both diseases start when the immune system stops tolerating its own thyroid proteins. In Hashimoto's, lymphocytes (a type of white blood cell) move into the gland and thyroid cells die off or change 3. The antibodies a lab measures, against thyroid peroxidase (TPO, the enzyme that builds thyroid hormone) and thyroglobulin (the protein that stores it), are footprints of that attack. The damage comes from the immune cells, and hormone output falls as working tissue is lost.

In Graves', the decisive antibody binds the TSH receptor, the switch the pituitary (a pea-sized gland under the brain) uses to tell the thyroid to work, and holds it on. The gland grows and makes hormone with no brake, which is why TSH drops close to zero. The pituitary has stopped asking, and the thyroid keeps going anyway 1. Twin studies put about 80% of the risk of Graves' down to genes, which fits with both diseases clustering in the same families 1. A high iodine intake, stress and pregnancy raise the odds of Graves' 1, and some medicines, notably interferon and amiodarone (a heart-rhythm drug), can set off thyroid problems in people already prone to them, as can the months after giving birth.

Smoking pushes the two in opposite directions. It raises the risk of Graves' and especially of Graves' eye disease, while people who smoke are less likely to carry TPO or thyroglobulin antibodies 13. That is a quirk of the immune system, and the eye risk alone makes it a strong reason to stop.

How it feels: slowed down vs sped up

Hashimoto's usually creeps in over years: tiredness, feeling cold, weight gain, constipation, dry skin and heavier periods. Many people only find out from a high TSH on a routine panel. Graves' arrives faster, with a racing or pounding heart, tremor, heat intolerance, weight loss despite a bigger appetite, anxiety and loose stools. Two features point almost only to Graves': eye changes, and in rare cases thick, reddened skin over the shins (pretibial myxedema). A racing or irregular heartbeat with chest pain, fainting or breathlessness, or a high fever with confusion, needs emergency care the same day. Our hypothyroidism vs hyperthyroidism page has the full symptom contrast and the rule behind the blood test: "TSH moves opposite to thyroid hormone."

The blood tests that tell them apart

How a thyroid panel narrows it down

1
TSH sets the direction
A high TSH means the pituitary is pushing a thyroid that is falling behind. A low TSH means there is already too much thyroid hormone in the blood.
2
Free T4 and free T3 set the degree
A free hormone outside its range means overt disease; a normal one with an abnormal TSH means mild (subclinical) disease. In Graves', free T3 sometimes rises first, so a normal free T4 with a very low TSH can still be overactive.
3
TPO antibodies confirm autoimmunity
Positive in about 90 to 95% of Hashimoto's 3, but also in about 70 to 80% of Graves' 5 and in about 11% of Americans who report no thyroid disease 4. Thyroglobulin antibodies add to it when TPO is negative. A positive result confirms autoimmunity and leaves the disease unnamed.
4
TRAb names Graves'
A positive TSH receptor antibody with a low TSH is the lab signature of Graves'. The 2018 European Thyroid Association guideline recommends it for diagnosis 1.
Order matters: the antibody is read against the direction TSH has already set.
98.3%of untreated Graves' cases caught by the newest TRAb testsWrongly positive in fewer than 1 in 100 people without Graves', pooled across 21 studies 2.

TRAb and TSI are two ways of measuring the same family of antibodies. Most labs run TRAb as a binding test, sometimes reported as TBII: it shows whether antibody is sitting on the receptor and how much, but not what the antibody does there 1. TSI (thyroid-stimulating immunoglobulin) is a cell-based test that measures the stimulating kind specifically, so a high TSI result with a low TSH points to Graves'. Both work for diagnosis, and the cell-based kind earns its place mainly in pregnancy and eye disease, where knowing whether the antibody stimulates or blocks changes the plan 1.

Many routine and direct-to-consumer thyroid panels include TSH, free T4 and TPO antibodies but no TRAb. A panel like that can show thyroid autoimmunity and an overactive gland side by side without naming the cause. If your TSH is low and TRAb was not run, ask your clinician to add it; if your TSH is high, ask for it to be repeated together with free T4 before any treatment decision. Our guide to reading a thyroid panel and TSH vs free T4 cover the hormone half, autoimmune antibodies explained covers how antibody tests behave in general, and every related page sits on the thyroid topic page.

Reading your pattern

Pattern on the reportWhat it often points toWhat usually comes next
High TSH, low or normal free T4, TPO positiveHashimoto's, overt or subclinicalA repeat TSH with free T4 to confirm it; treatment then follows TSH and free T4, whatever the antibody level 3
Normal TSH and free T4, TPO positiveThyroid autoimmunity without thyroid failureA TSH check about once a year: about 2% of women a year go on to an underactive thyroid, about 4% a year if TSH is already raised 11
Low TSH, high free T4 or free T3, TRAb positiveGraves' disease 1Referral to an endocrinologist (a hormone specialist) and an eye check
Low TSH, high free T4, TRAb negative, TPO positivePainless or postpartum thyroiditis (a temporary leak from Hashimoto's) or an overactive nodule 3; less often, Graves' with a negative TRAb (about 2%) 2A repeat panel within a few weeks, plus Doppler ultrasound or an uptake scan if it has not settled
TPO positive and TRAb positiveGraves' with background thyroiditis, or a person switching between the two 6Read with TSH direction and symptoms over time
Low TSH, high free T4, TRAb positive, few symptoms, taking biotinPossible biotin interference 9Tell the lab and the clinician before any retest

These patterns are a starting point for the conversation with your doctor, who confirms the diagnosis with your full history and, where needed, a repeat test or scan. The second row is the most common surprise. Our Hashimoto's disease page puts it in one line: "Hashimoto's is the cause; hypothyroidism is the state." A positive TPO antibody with a normal TSH means the immune process is there and the gland is still keeping up.

The last row catches people out. High-dose biotin, common in hair, skin and nail supplements, can push TSH falsely low and free T4 and TRAb falsely high on some lab platforms, which adds up to a complete fake Graves' picture 9. The tell is numbers that say overactive thyroid in a body that shows none of the signs. The biotin and blood tests page covers which tests are affected and how long the effect lasts.

A single wrong number would look like a lab glitch; two wrong numbers that agree with each other look like a diagnosis.

LifeFrom, Biotin before a blood test
Free, no accountRead your blood testGot a thyroid panel with TSH, free T4 and antibodies on it? Read what every line means, free, and take the questions it raises to your doctor.Read my results

When blood tests aren't enough: ultrasound and the uptake scan

The European guideline sums up the full Graves' picture in one sentence. In its wording, GD is Graves' disease, TSH-R-Ab is TRAb, thyrotoxicosis is too much thyroid hormone and orbitopathy is eye disease.

Diagnosis of GD is straightforward in a patient with biochemically confirmed thyrotoxicosis, positive TSH-R-Ab, a hypervascular and hypoechoic thyroid gland (ultrasound), and associated orbitopathy.Kahaly et al., 2018 European Thyroid Association guideline 1

On Doppler ultrasound, untreated Graves' often shows blood flow so heavy that radiologists sometimes call it "thyroid inferno", while flow is low in thyroiditis. Hashimoto's shows a darker, uneven gland (reduced echogenicity) on a standard scan 3. When the cause of an overactive thyroid is not clear, the American Thyroid Association guideline lists TRAb, an uptake scan or Doppler ultrasound as the ways to settle it 14.

A radioactive iodine uptake scan measures how hard the gland is working. Uptake is high and even across the gland in Graves', and low in painless or postpartum thyroiditis, because that gland is leaking stored hormone instead of making new. With a positive TRAb the scan is rarely needed. Radioactive iodine treatment is ruled out in pregnancy and breastfeeding 1, and the scan's tracer is avoided then too. An enlarged gland of either kind is covered on the goiter page.

Can you have both, or can one turn into the other?

Yes, though it is uncommon. A person can carry both antibody sets, and the thyroid can move from one state to the other in three ways.

  1. Graves' treated into hypothyroidism. Radioactive iodine is usually given at a dose meant to leave the gland underactive, and surgery removes it outright, so most people end up on lifelong levothyroxine 14, with a lab picture that looks like treated Hashimoto's.
  2. The pendulum. TSH receptor antibodies come in a stimulating kind and a blocking kind. When the balance between them shifts, a person can swing from overactive to underactive, or the reverse, months or years apart 6.
  3. Hashitoxicosis. Early Hashimoto's can leak stored hormone and look overactive for a few weeks. TRAb is negative, the uptake scan is low, and the overactive phase ends on its own 3.

The researchers who mapped the pendulum use three abbreviations: TBAb is the blocking antibody, TSAb the stimulating one and LT4 is levothyroxine.

Switching between TBAb and TSAb (or vice versa) occurs in unusual patients after LT4 therapy for hypothyroidism or anti-thyroid drug treatment for Graves' disease.McLachlan and Rapoport, Thyroid, 2013 6

For anyone already diagnosed, a repeat TSH and free T4 shows which way the thyroid moved when symptoms flip direction. Someone on levothyroxine for Hashimoto's who develops a racing heart, weight loss or tremor should contact their prescriber; the most common cause is a dose that is now too high, which a TSH check shows. If TSH stays low after the dose is corrected, or eye changes appear, that is the time to ask about a TRAb test.

Treatment: replacing hormone vs slowing the gland

Hashimoto's usually needs no hormone treatment while TSH and free T4 stay normal; pregnancy and planning one are the main exceptions, where the doctor may treat sooner. Once hormone output falls, treatment replaces it with synthetic thyroid hormone, levothyroxine, and the dose follows TSH, whatever the antibody level 3. For mild (subclinical) disease, treatment is generally offered once TSH stays above 10, and TSH is rechecked some weeks after each dose change. Our hypothyroidism page covers when treatment starts.

Graves' treatment slows the gland or removes it. A beta-blocker calms the heart rate and tremor while the other treatment takes effect 1. Methimazole is the first-choice drug, usually for 12 to 18 months, and about half of people stay in remission after that course 1. A TRAb test before stopping helps predict who will relapse, and people whose TRAb is still high can carry on with the drug or move to a definitive option 1. Radioactive iodine and surgery are those definitive options, and both usually lead to lifelong levothyroxine 14. More on the overactive side is on the hyperthyroidism page.

Graves' eye disease

The TSH receptor also sits on cells behind the eye, so the antibody that drives Graves' can inflame the fat and muscle there (Graves' orbitopathy) 5. It affects roughly 1 in 4 people with Graves', most often mildly, and shows up as gritty, red or watering eyes, puffy lids, a staring look, bulging eyes or double vision 12. Hashimoto's rarely affects the eyes. Smoking is the strongest risk you can change, and stopping is the first recommendation 12. Radioactive iodine can set off or worsen eye disease, which is why it is avoided in active moderate-to-severe or sight-threatening eye disease and given with steroid cover in mild active disease 1. For mild active eye disease, a 6-month selenium course improved quality of life and slowed progression compared with placebo in one European trial 8, and the eye guideline accepts it where selenium intake runs low 12. It is a decision for the eye or thyroid specialist, and more selenium is not better, because high doses are toxic; see selenium.

Pregnancy and planning one

TRAb crosses the placenta and can make the baby's thyroid overactive, even when the mother's own Graves' was treated years ago with radioactive iodine or surgery. Anyone with current or past Graves' should have TRAb measured early in pregnancy and, if it is raised, again at 18 to 22 weeks; a level above about 3 times the upper limit calls for monitoring the baby's thyroid 10. Methimazole is usually switched to PTU when planning pregnancy and in the first trimester 1. On the Hashimoto's side, women with positive TPO antibodies have a higher risk of miscarriage and of postpartum thyroiditis, and levothyroxine doses usually need to go up early in pregnancy 10. Postpartum blood tests covers the months after.

Diet, selenium and vitamin D: what the evidence supports

Neither disease is cured by diet. Selenium lowers TPO antibody numbers in Hashimoto's trials, but a Cochrane review found the evidence too incomplete to say it improves how people feel or how the thyroid works 7; its one guideline-backed use is mild active Graves' eye disease, under an eye specialist's care 12. Low vitamin D is common in both conditions, and the vitamin D page grades the trials that tried correcting it. A gluten-free diet matters when celiac disease is confirmed. A high iodine intake raises the risk of Graves' 1, so kelp tablets and high-dose iodine supplements are a poor fit for either condition. Other autoimmune conditions tend to travel with both, including pernicious anemia, type 1 diabetes and celiac disease itself.

Which is more serious?

Untreated Graves' is the more urgent of the two. Untreated hyperthyroidism leads to weight loss, osteoporosis and fractures, atrial fibrillation and the strokes it can cause, and in rare cases thyroid storm, a crisis that can be fatal 14. Hashimoto's moves slower, and its harms (raised cholesterol, tiredness, and in rare untreated cases myxedema coma, a dangerously slowed body) build over years. A low TSH with symptoms warrants a prompt appointment; a high TSH can usually wait for a routine one unless the warning signs below appear.

Free, no accountDrop in your lab report and see every marker explained in plain words, placed on the body, against your lab's range. It's read on your device: nothing is uploaded and nothing is kept.

Questions

Can you have Hashimoto's and Graves' at the same time?

Yes, uncommonly. Some people test positive for both TPO antibodies and TSH receptor antibodies, and some swing between an overactive and an underactive thyroid as the balance of stimulating and blocking TSH receptor antibodies shifts 6. TSH at the time of testing shows which disease is in charge.

Can TPO antibodies be high in Graves' disease?

Yes. TPO antibodies are positive in about 70 to 80% of people with Graves' 5, as well as in about 90 to 95% of people with Hashimoto's 3 and about 11% of Americans with no known thyroid disease 4. That is why a TPO result alone cannot tell the two apart.

Is TSI the same as TRAb?

They measure the same antibody family in different ways. TRAb is a binding test that shows antibody on the TSH receptor; TSI is a cell-based test that shows the antibody is stimulating the receptor. Both diagnose Graves'; TSI adds most in pregnancy and eye disease 1.

Which is worse, Hashimoto's or Graves'?

Untreated Graves' is the more immediately dangerous, because an overactive thyroid can trigger atrial fibrillation, bone loss and, rarely, thyroid storm 14. Hashimoto's harms build more slowly. Both can usually be controlled with treatment.

Can Hashimoto's turn into Graves'?

Rarely. A shift from blocking to stimulating TSH receptor antibodies has been reported in people already on levothyroxine 6. More often, a short overactive phase in Hashimoto's is a temporary leak of stored hormone (hashitoxicosis) with a negative TRAb 3.

Citations
  1. Kahaly GJ, Bartalena L, Hegedüs L, Leenhardt L, Poppe K, Pearce SH. 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism. Eur Thyroid J. 2018;7(4):167-186.
  2. Tozzoli R, Bagnasco M, Giavarina D, Bizzaro N. TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis. Autoimmun Rev. 2012;12(2):107-113.
  3. Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391-397.
  4. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499.
  5. Smith TJ, Hegedüs L. Graves' Disease. N Engl J Med. 2016;375(16):1552-1565.
  6. McLachlan SM, Rapoport B. Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid. 2013;23(1):14-24.
  7. van Zuuren EJ, Albusta AY, Fedorowicz Z, Carter B, Pijl H. Selenium supplementation for Hashimoto's thyroiditis. Cochrane Database Syst Rev. 2013;(6):CD010223.
  8. Marcocci C, Kahaly GJ, Krassas GE, et al. Selenium and the course of mild Graves' orbitopathy. N Engl J Med. 2011;364(20):1920-1931.
  9. Kummer S, Hermsen D, Distelmaier F. Biotin treatment mimicking Graves' disease. N Engl J Med. 2016;375(7):704-706.
  10. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27(3):315-389.
  11. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43(1):55-68.
  12. Bartalena L, Kahaly GJ, Baldeschi L, et al. The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy. Eur J Endocrinol. 2021;185(4):G43-G67.
  13. Wiersinga WM. Smoking and thyroid. Clin Endocrinol (Oxf). 2013;79(2):145-151.
  14. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343-1421.

Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.